Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perirectal spacers and endorectal balloons in external beam radiotherapy for prostate cancer: a review of prospective studies.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Same author

Robust Four-Field and Arc LET-Optimized Proton Prostate Cancer Treatment Plans With Urethral Sparing.

International journal of particle therapy·2026
Same author

Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer.

International journal of particle therapy·2026
Same author

Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Comparing Organs at Risk Sparing Between Intensity-Modulated Radiotherapy and Pencil-Beam Scanning Plans Based on Disease Location for Hodgkin and Non-Hodgkin Lymphoma.

International journal of particle therapy·2026
Same author

Management of a Multi-Room Downtime Event in a Multi-System Environment: A Case Report in Proton Therapy Operations.

International journal of particle therapy·2026

Related Experiment Video

Updated: May 29, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Proton therapy for prostate cancer.

Bradford Hoppe1, Randal Henderson, William M Mendenhall

  • 1University of Florida Proton Therapy Institute, Jacksonville, Florida 32206, USA. bhoppe@floridaproton.org

Oncology (Williston Park, N.Y.)
|September 6, 2011
PubMed
Summary

Proton therapy offers precise radiation for prostate cancer, showing high control rates and low toxicity. Ongoing research aims to improve its effectiveness and cost-efficiency.

More Related Videos

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Related Experiment Videos

Last Updated: May 29, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Proton therapy utilizes a unique Bragg peak for precise radiation delivery, sparing adjacent critical structures.
  • Prostate cancer treatment benefits from proton therapy due to the prostate's proximity to the rectum and bladder.
  • Extensive data over 30 years confirm high efficacy and low toxicity for proton therapy in prostate cancer.

Purpose of the Study:

  • To review the established benefits and ongoing research in proton therapy for prostate cancer.
  • To highlight advancements in proton therapy techniques and their impact on treatment outcomes.
  • To discuss the evolving landscape of proton therapy accessibility and cost-effectiveness.

Main Methods:

  • Review of over 30 years of published data on proton therapy for prostate cancer.
  • Analysis of current research trends including dose escalation and hypofractionation.
  • Evaluation of patient-reported quality-of-life outcomes.

Main Results:

  • Proton therapy demonstrates high rates of local and biochemical control for prostate cancer.
  • Low rates of urinary and rectal toxicity are consistently reported with proton therapy.
  • Increased availability of proton therapy centers is driving accelerated research.

Conclusions:

  • Proton therapy is a well-established and effective treatment for prostate cancer with a favorable toxicity profile.
  • Current research in dose escalation, hypofractionation, and quality of life promises further optimization.
  • Advancements in proton therapy are expected to enhance its cost-effectiveness for prostate cancer treatment.